Related Experiment Video
Updated: Jul 20, 2026

Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma
Published on: December 29, 2023
Marjolin's ulcer arising from a laparostomy scar
P Yuste García1, P Villarejo Campos, J M Menéndez Rubio
1General and Digestive Surgery Department, Hospital Universitario 12 de Octubre, Madrid, Spain. yustep@jazzfree.com
Marjolin's ulcer, a rare squamous cell carcinoma, can develop from laparostomy scars. Early wound care and infection treatment are crucial for preventing this malignant transformation.
Area of Science:
- Oncology
- Dermatology
- Surgical Pathology
Background:
- Marjolin's ulcer is a malignant transformation of chronic scars, typically squamous cell carcinoma.
- It uncommonly presents in laparostomy scars, requiring surgical intervention.
Observation:
- A 49-year-old patient developed a 20-cm ulcer on a laparostomy scar 13 years post-treatment for necrohemorrhagic pancreatitis.
- The ulcer was diagnosed as invasive squamous cell carcinoma.
Findings:
- Surgical resection of the abdominal wall and transverse colectomy were performed due to cancer infiltration.
- Axillary lymphadenectomy was necessary for lymph node metastasis, indicating frequent nodal involvement in such cases.
Implications:
- Squamous cell carcinoma arising from Marjolin's ulcers, especially with lymph node metastasis, has a poor prognosis.
- Preventive measures include diligent wound care, timely skin grafting, and infection management to reduce Marjolin's ulcer risk.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Healing II: Complications
